Vaisala Group
Vaisala Corporation: Share Repurchase 25.8.2025
Vaisala Corporation: Share Repurchase 25.8.2025
| VAISALA CORPORATION | STOCK EXCHANGE RELEASE 25.8.2025 | |
| Vaisala Corporation: Share Repurchase 25.8.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 25.8.2025 | |
| Bourse trade | Buy | |
| Share | VAIAS | |
| Amount | 3 011 | Shares |
| Average price/ share | 46,9572 | EUR |
| Total cost | 141 388,13 | EUR |
| Vaisala Corporation now holds a total of 144 995 shares | ||
| including the shares repurchased on 25.8.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Vaisala Corporation | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
More information:
Niina Ala-Luopa
+358 400 728 957, ir@vaisala.com
Distribution:
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. www.vaisala.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oil-Dri Corporation Of America25.8.2025 22:00:00 CEST | Press release
Amlan® to Present on Biotoxin Control and Antibiotic-Free Poultry Production at Malaysia Livestock 2025
King Faisal Specialist Hospital & Research Centre25.8.2025 21:16:42 CEST | Press release
Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy
F. Hoffmann-La Roche Ltd25.8.2025 20:30:00 CEST | Press release
Roche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA
Recor Medical25.8.2025 18:21:49 CEST | Press release
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
Bang & Olufsen A/S25.8.2025 17:17:32 CEST | Press release
Bang & Olufsen A/S – share buyback programme to hedge the company’s share-based incentive programmes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom